Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 286 shares (to pay taxes)
  3. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
  4. 4 Option exercise INTERIM PRESIDENT AND CEO acquired 43,548 shares (option exercise)
  5. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
  6. 4 Open-market buy 10% owner bought 373,569 shares at an average $1.27 ($472,757)
  7. 4 Open-market buy 10% owner bought 273,730 shares at an average $1.31 ($359,010)
  8. 4 Open-market buy 10% owner bought 154,722 shares at an average $1.30 ($201,808)
  9. 4 Open-market buy 10% owner bought 352,397 shares at an average $1.15 ($405,894)
  10. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)
  11. 4 Open-market buy 10% owner bought 1,543,434 shares at an average $1.13 ($1,742,075)
  12. 4 Open-market buy 10% owner bought 545,000 shares at an average $1.15 ($628,206)
  13. 4 Open-market buy 10% owner bought 1,611,200 shares at an average $1.11 ($1,781,897)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,722 shares (to pay taxes)

Page 4 of 21 · 414 filings